Global Oral Anticoagulants Market By Drug Class(Vitamin K Antagonists, Direct Oral Anticoagulants) By Indication (Non-valvular Atrial Fibrillation (NVAF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Post-orthopedic Surgery Thromboprophylaxis, Others) By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Nov 2025
- Report ID: 166737
- Number of Pages: 313
- Format:
-
keyboard_arrow_up
-
-
- Pfizer Inc.
- Bristol Myers Squibb Company
- Bayer
- Johnson & Johnson
- Boehringer Ingelheim International GmbH
- Daiichi Sankyo Company, Limited
- Sanofi S.A.
- GSK plc
- AstraZeneca plc
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy’s Laboratories Ltd.
- Aspen Holdings
- Eisai Co., Ltd.
- Portola Pharmaceuticals, Inc.
Our Clients
- 166737
- Nov 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
